[1]
“Idiopathic genital pyoderma gangrenosum successfully treated with infliximab biosimilar”, J Pak Assoc Dermatol, vol. 34, no. 4 Suppl., pp. S125-S128, Dec. 2024, doi: 10.66344/jpad.v34i4(Suppl).2987.